Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.34
12.09.22
-
12.09.23
-93.70%
02.04.23

Could be very worthwhile Investment >20% year
Vassago1 
12.09.22 50%
sell
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.25
31.03.23
-
31.03.24
-4.55%
01.04.23

kugelmann 
31.03.23 0%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
me8 
20.03.23 0%
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
21.07.22 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.86
28.01.22
€7.20
28.01.23
-32.31%
29.01.23

melinda 
28.01.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.58
17.11.22
-
17.11.23
-14.78%
26.12.22

Global_Player 
17.11.22 50%
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€0.98
14.12.21
-
14.12.22
-39.08%
15.12.22

Could be worthwhile Investment >10% per year
melinda 
14.12.21 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Maxi_Scalibusa 
01.12.21 0%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
20.09.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.59
03.11.22
-
03.11.23
-6.74%
12.11.22

Global_Player 
03.11.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.35
03.11.22
-
03.11.23
-5.40%
12.11.22

thomasw 
03.11.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.12
23.10.22
-
23.10.23
-24.89%
03.11.22

Global_Player 
23.10.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.18
04.09.22
-
04.09.23
-9.84%
01.10.22

Global_Player 
04.09.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
03.08.22 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.16
24.07.22
-
24.07.23
-2.64%
04.09.22

quelbe60 
24.07.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
Vassago1 
24.08.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
26.08.22
-
26.08.23
-4.98%
03.09.22

Vassago1 
26.08.22 50%
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.40
29.11.21
-
29.11.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
29.11.21 0%
sell
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.40
04.10.21
-
04.10.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
04.10.21 0%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.81
04.07.22
-
04.07.23
-24.63%
06.08.22

Could be worthwhile Investment >10% per year
Vassago1 
04.07.22 50%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
28.04.22 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.09
10.07.22
-
10.07.23
1.76%
23.07.22

blaugold 
10.07.22 50%
sell
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.93
09.07.22
€4.00
09.07.23
-40.65%
23.07.22

mixitrader 
09.07.22 50%
sell
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.41
05.12.21
€3.00
05.12.22
-0.78%
21.07.22

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
05.12.21 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.27
27.06.22
-
27.06.23
-4.35%
09.07.22

daimler1 
27.06.22 50%